Choriocarcinoma/Molar/Trophoblastic – Bravelets

Free Standard Shipping on ALL Orders!

You are shopping with [affiliate]! Shop Now

Thank you for supporting [affiliate]! This fundraiser will earn 25% from your purchase! Shop Now


10% of purchases made will be donated to Choriocarcinoma/Molar/Trophoblastic Learn more

  • Filter by Cause

About this cause:

Choriocarcinoma is a rare placental cancer that is a type of gestational trophoblastic disease. It is a fast-growing and aggressive form of cancer that occurs in a woman's uterus at conception when abnormal cells start in the tissue of what would be the placenta. It is usually from a molar pregnancy, both partial and complete moles, both hydatidiform moles (complete moles have higer percentage) but can happen at any type of pregnancy, miscarriage, ectopic, abortion or leftover placental fragments. Choriocarcinoma are grape-like germ cell clusters that travel from the uterus to the lungs, liver, and finally the brain. Chemotherapy is needed and sometimes surgery. It is highly treatable if caught in time and responds well to chemo. B-HCG levels will be high and treatment includes monitoring this pregnancy hormone level.

Dr. Goldstein at Brigham and Women's Hospital holds exclusive research on this pregnancy disease and its cancer. The Choriocarcinoma Research Fund supports his work and is used for research and treatment, uncovering new ways to detect and treat, thus providing life-giving breakthroughs to patients and their families everywhere. Donald Goldstein, M. D. founded the New England Trophoblastic Disease Center in 1965, which was the first regional center in the country devoted solely to the treatment of gestational trophoblastic disease.